会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • LYSINE SPECIFIC DEMETHYLASE-1 INHIBITORS AND THEIR USE
    • LYSINE SPECIFIC DEMETHYLASE-1 INHIBITORS及其使用
    • WO2011035941A1
    • 2011-03-31
    • PCT/EP2010/055131
    • 2010-04-19
    • ORYZON GENOMICS S.A.ORTEGA MUÑOZ, AlbertoCASTRO-PALOMINO LARIA, JulioFYFE, Matthew Colin Thor
    • ORTEGA MUÑOZ, AlbertoCASTRO-PALOMINO LARIA, JulioFYFE, Matthew Colin Thor
    • C07D207/14C07D211/14C07D241/04C07C211/35C07C43/115C07C321/14A61K31/075A61K31/095A61K31/40A61K31/495A61P35/00
    • C07D241/04A61K31/075A61K31/095A61K31/40A61K31/495A61K45/06C07C211/40C07C217/08C07C217/74C07C323/25C07C2601/02C07D207/14C07D211/14A61K2300/00
    • The invention relates to a compound of Formula (I): (A') x -(A)-(B)-(Z)-(L)-(D), wherein: (A) is heteroaryl or aryl; each (A'), if present, is independently chosen from aryl, arylalkoxy, arylalkyl, heterocyclyl, aryloxy, halo, alkoxy, haloalkyl, cycloalkyl, haloalkoxy, and cyano, wherein each (A') is substituted with 0, 1, 2, or 3 substituents independently chosen from halo, haloalkyl, aryl, arylalkoxy, alkyl, alkoxy, cyano, sulfonyl, amido, and sulfinyl; X is 0, 1, 2, or 3; (B) is a cyclopropyl ring, wherein (A) and (Z) are covalently bonded to different carbon atoms of (B); (Z) is -NH-; (L) is chosen from -CH 2 CH 2 -, -CH 2 CH 2 CH 2 -, and -CH 2 CH 2 CH 2 CH 2 -; and (D) is chosen from -N(-R1)-R2, -O-R3, and -S-R3, wherein: R1 and R2 are mutually linked to form a heterocyclic ring together with the nitrogen atom that R1 and R2 are attached to, wherein said heterocyclic ring has 0, 1, 2, or 3 substituents independently chosen from -NH 2 , -NH(C 1 -C 6 alkyl), -N(C 1 -C 6 alkyl)(C 1 -C 6 alkyl), alkyl, halo, cyano, alkoxy, haloalkyl, and haloalkoxy, or R1 and R2 are independently chosen from -H, alkyl, cycloalkyl, haloalkyl, and heterocyclyl, wherein the sum of substituents on R1 and R2 together is 0, 1, 2, or 3, and the substituents are independently chosen from -NH 2 , -NH(C 1 -C 6 alkyl), -N(C 1 -C 6 alkyl)(C 1 -C 6 alkyl), and fluoro; and R3 is chosen from -H, alkyl, cycloalkyl, haloalkyl, and heterocyclyl, wherein R3 has 0, 1, 2, or 3 substituents independently chosen from -NH 2 , -NH(C 1 -C 6 alkyl), -N(C 1 -C 6 alkyl)(C 1 -C 6 alkyl), and fluoro; or an enantiomer, diastereomer, or mixture thereof, or a pharmaceutically acceptable salt or solvate thereof. The compounds of the invention show inhibitory LSD1 activity, which makes them useful in the treatment or prevention of diseases such as cancer.
    • 本发明涉及式(I)化合物:(A')x-(A) - (B) - (Z) - (L) - (D),其中:(A)是杂芳基或芳基; 每个(A')如果存在,独立地选自芳基,芳基烷氧基,芳基烷基,杂环基,芳氧基,卤素,烷氧基,卤代烷基,环烷基,卤代烷氧基和氰基,其中每个(A')被0,1,2 或3个独立地选自卤素,卤代烷基,芳基,芳基烷氧基,烷基,烷氧基,氰基,磺酰基,酰氨基和亚磺酰基的取代基。 X为0,1,2或3; (B)是环丙基环,其中(A)和(Z)与(B)的不同碳原子共价结合; (Z)为-NH-; (L)选自-CH 2 CH 2 - , - CH 2 CH 2 CH 2 - 和-CH 2 CH 2 CH 2 CH 2 - ; 和(D)选自-N(-R 1)-R 2,-O-R 3和-S-R 3,其中:R 1和R 2相互连接,与氮原子一起形成杂环,R1和R2是 其中所述杂环具有0,1,2或3个独立地选自-NH 2,-NH(C 1 -C 6烷基), - N(C 1 -C 6烷基)(C 1 -C 6烷基),烷基,卤素 ,氰基,烷氧基,卤代烷基和卤代烷氧基,或者R 1和R 2独立地选自-H,烷基,环烷基,卤代烷基和杂环基,其中R 1和R 2上的取代基之和为0,1,2或3, 并且取代基独立地选自-NH 2,-NH(C 1 -C 6烷基),-N(C 1 -C 6烷基)(C 1 -C 6烷基)和氟; 并且R 3选自-H,烷基,环烷基,卤代烷基和杂环基,其中R 3具有0,1,2或3个独立地选自-NH 2,-NH(C 1 -C 6烷基), - N(C 1 -C 6) 烷基)(C 1 -C 6烷基)和氟; 或其对映体,非对映体或其混合物,或其药学上可接受的盐或溶剂合物。 本发明化合物显示抑制性LSD1活性,使其可用于治疗或预防癌症等疾病。